GOLDMAN SACHS: These are the 12 stocks most loved by hedge funds
Reuters / Brendan McDermid
- Hedge funds disclosed their most recent holdings in public filings earlier this month, providing a window into which companies some of the world's most successful money managers are betting on.
- Goldman Sachs put together a list of the stocks that appear most frequently in the top 10 largest holdings within hedge fund portfolios.
- The "Hedge Fund VIP List" features the top long positions of fundamentally-driven hedge funds, excluding firms that use quantitative strategies or attempt to mirror private equity investments.
- Here are 12 companies most loved by hedge funds in the second quarter.
- Visit the Markets Insider homepage for more stories.
Earlier this month, hedge funds revealed which public companies they bought and sold during the second quarter.
Hedge funds are required to disclose stakes in public companies four times a year, following the end of each quarter. Goldman Sach's created a list of the top stocks these money managers purchased in the second quarter based publicly-available 13F filings.
Goldman's "Hedge Fund VIP List" includes the top long positions of fundamentally-driven hedge funds. The firm's analysis was limited to funds with between ten and 200 equity positions in effort to exclude funds that apply quantitative strategies or attempt to mirror private equity investments.
When hedge funds show interest in a particular stock, its often a good sign, according to Goldman's analysis.
"Changes in popularity with hedge fund investors can be strong signals for future stock performance," the firm said in the report.
Here the 12 stocks most loved by hedge funds in the second quarter, ranked in increasing order of how many have them in their top 10 holdings:
- ‘Padman of 2022’: Shark Peyush Bansal offers founder of women’s hygiene startup PadCare a blank cheque
- Gautam Adani lost $52 billion in 6 days. That's over 3 times what Sam Bankman-Fried lost in a similar timeframe.
- A 45-year-old biotech CEO may have reduced his biological age by at least 5 years through a rigorous medical program that can cost up to $2 million a year, Bloomberg reported
- Revival of rural economy to take time in the absence of triggers: JM Financial
- Logistics startup FarEye lays off 90 employees, 2nd job cut in 8 months
- Vani Jayaram, the voice behind 10,000 songs, passes away at 78
- Not the first time FPO is taken back, won't affect image of the country: FM
- India's cancer cases will surge to 20 lakh per year by 2026: AIIMS